Your browser doesn't support javascript.
loading
GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy.
Wasserman, Jason K; Williams, Phillip A; Islam, Shahidul; Robertson, Susan J.
Affiliation
  • Wasserman JK; University of Ottawa, Pathology & Laboratory Medicine, Ottawa, Ontario, Canada.
  • Williams PA; University of Ottawa, Pathology & Laboratory Medicine, Ottawa, Ontario, Canada.
  • Islam S; University of Ottawa, Pathology & Laboratory Medicine, Ottawa, Ontario, Canada.
  • Robertson SJ; University of Ottawa, Pathology & Laboratory Medicine, Ottawa, Ontario, Canada. Electronic address: sjrobertson@toh.on.ca.
Pathol Res Pract ; 212(6): 539-44, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27067807
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy, Adjuvant / Carcinoma, Ductal, Breast / Neoadjuvant Therapy / GATA3 Transcription Factor / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Pathol Res Pract Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy, Adjuvant / Carcinoma, Ductal, Breast / Neoadjuvant Therapy / GATA3 Transcription Factor / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Pathol Res Pract Year: 2016 Document type: Article Affiliation country: Country of publication: